Results 91 to 100 of about 12,212 (162)

Telmisartan-poly (ethylene glycol) conjugate augmented drug dissolution and permeability in cervical cancer cells [PDF]

open access: yes, 2019
Telmisartan is currently reported for inhibiting cervical cancer cells. Despite favorable therapeutic profile, poor aqueous solubility and low oral bioavailability limit its therapeutic application in treatment of cervical cancer.
Sharma, Rahul   +2 more
core   +1 more source

Telmisartan/hydrochlorothiazide: a new fixed dose combination

open access: yes, 2005
Many patients with hypertension require two or more antihypertensive drugs with complementary mechanisms of action to lower their blood pressure and attain the therapeutic goals specified in internationally accepted guidelines.
Burnier, M., Maillard, M.
core   +1 more source

EVALUATION OF THE ANTI-INFLAMMATORY EFFECT OF TELMISARTAN AS AN ADJUVANT THERAPY TO NSAID IN THE MANAGEMENT OF KNEE OSTEOARTHRITIS; A CLINICAL PROSPECTIVE STUDY

open access: yesThe Iraqi Journal of Medical Sciences, 2018
Background: Osteoarthritis (OA) is a degenerative joint disease caused by gradual loss of cartilage. Telmisartan is an angiotensin II receptor antagonist, and act as a partial agonist on the nuclear peroxisome proliferator-activated receptor-gamma (PPAR ...
Sarah Hmood   +3 more
doaj   +1 more source

A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours

open access: yes, 2006
Philippe Gosse  Service de Cardiologie – Hypertension artérielle, Hôpital Saint André, Bordeaux Cedex, FranceAbstract: Measurement of blood pressure in the clinic may provide a false impression of blood pressure control ...
Philippe Gosse
core  

Three spectrophotometric quantitative analysis of bisoprolol fumarate and telmisartan in fixed-dose combination utilizing ratio spectra manipulation methods

open access: yesScientific Reports
Hypertension is a chronic condition with multiple drug regimens. Limiting these medicines is critical to patient compliance. Therefore, bisoprolol and telmisartan were recently developed in a fixed-dose combination to control blood pressure.
Osama I. Abdel Sattar   +3 more
doaj   +1 more source

Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care

open access: yes, 2010
Frederic Kontny1, Terje Risanger2, Arne Bye3, Øyvind Arnesen4, Odd Erik Johansen4 for the TELMIMORE Study Investigators51Dept of Cardiology, Volvat Medical Centre, Oslo, Norway; 2Prinsdal Health Centre, Oslo, Norway; 3Frosta Health Centre ...
Arne Bye   +3 more
core  

SIMULTANEOUS ESTIMATION OF TELMISARTAN AND HYDROCHLOROTHIAZIDE BY DERIVATIVE SPECTROSCOPY [PDF]

open access: yes, 2015
Objective: The objective of this investigation is to present the simple and sensitive method for the analysis of Telmisartan and Hydrochlorothiazide and apply the proposed method for the analysis of said drugs in pharmaceutical formulations.Methods ...
Shakya, Piusha   +3 more
core   +1 more source

Contemporary management of hypertension with telmisartan [PDF]

open access: yes, 2013
Telmisartan je dugodjelujući, snažan, vrlo selektivan antagonist AT1 receptora angiotenzina II. Omogućuje preciznije i potpunije blokadu djelovanja angiotenzina II od ACE inhibitora.
Primožič, Aleša   +5 more
core   +1 more source

Clinical use of a fixed-dose combination of telmisartan and indapamide in hypertension. Expert Council resolution

open access: yesРоссийский кардиологический журнал
The aim of the expert council "First star duo of telmisartan and indapamide in the Russian Federation", dedicated to the introduction of a new fixed-dose combination of telmisartan and indapamide (modified-release tablets) into clinical practice was to ...
A. O. Konradi   +8 more
doaj   +1 more source

Comparative Efficacies of Amlodipine-Telmisartan Versus Cilnidipine-Telmisartan in the Management of Hypertension [PDF]

open access: yes
Background: Hypertension is a common cardiovascular issue that necessitates efficient pharmacological management to avoid complications. Calcium channel blockers together with angiotensin receptor blockers are frequently recommended. This research sought
Jyoti Kumari Upadhyay
core   +1 more source

Home - About - Disclaimer - Privacy